Additionally, 35% of subjects in the Tesamorelin group achieved a hepatic fat fraction below 5%, compared to only 4% in the control group
Griffeth RJ, Bianda V, Nef S
Available at: Orforglipron (Foundayo) A Second Oral GLP-1 Receptor Agonist for Weight Loss
Currently licensed weight management medications in the UK include: Orlistat (lipase inhibitor that reduces fat absorption) Wegovy (semaglutide injection) for chronic weight management (typically BMI 35 kg/m, or 30 kg/m with weight-related comorbidities, via specialist weight management services) [13] Saxenda (liraglutide injection) , another GLP-1 receptor agonist (typically BMI 35 kg/m, or 30 kg/m with weight-related comorbidities) Mysimba (naltrexone/bupropion) is licensed but not routinely commissioned by the NHS [15] [16] NICE recommends lower BMI thresholds (typically 2.5 kg/m lower) for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds
Checking it can stop bigger issues later
Effective & professional doctor-led Mounjaro at our central London clinic Verified Before & After Verified Before & After MHRA Guidance: Use non-hormonal contraception (eg, patch, ring, IUD) during therapy